No Carolina / NY / Florida
Ph: 561.316.3330

spot_img

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

The new Roden ADA Kit expedites bioanalysis by removing the need for assay development and optimization across molecules to provide robust, reproducible, reliable data from nanoliter sample volumes. This is beneficial when ADA assessment is evaluated in preclinical animal models where sample volume may be limited.

As AAOS Sees Record Growth in Fracture & Trauma Registry Data Submissions, Technology Partnership Offering with PatientIQ Expands to Include Nationwide Participation Options

Summation

  • AAOS partnered with PatientIQ in December 2022 to integrate its cloud-based platform directly with FTR participants' electronic health records (EHR) and simplify the process to collect and submit registry data for five of the more common fractures in the U.
  • On the heels of a successful technology pilot program with PatientIQ, the American Academy of Orthopaedic Surgeons (AAOS) has seen a rapid increase in data submissions to the Fracture &.
  • Through the submission and analysis of data to the FTR, healthcare systems and orthopaedic surgeons can actively utilize the knowledge gained to improve outcomes and the quality of orthopaedic care in turn supporting highly informed decision-making and quality improvement.

On the heels of a successful technology pilot program with PatientIQ, the American Academy of Orthopaedic Surgeons (AAOS) has seen a rapid increase in data submissions to the Fracture & Trauma Registry (FTR). Through the submission and analysis of data to the FTR, healthcare systems and orthopaedic surgeons can actively utilize the knowledge gained to improve outcomes and the quality of orthopaedic care in turn supporting highly informed decision-making and quality improvement.

AAOS partnered with PatientIQ in December 2022 to integrate its cloud-based platform directly with FTR participants’ electronic health records (EHR) and simplify the process to collect and submit registry data for five of the more common fractures in the U.S. Within the first eight months, the partnership yielded a substantial increase in data submitted to the FTR. By expanding the participation options to include the PatientIQ solution, the FTR is reducing barriers to tracking evidence-based practices and advancing the delivery of musculoskeletal care. To date, there are 35 participating sites contributing to the FTR.

Michael J. Gardner, MD, FAAOS,
chair of the AAOS Fracture & Trauma Registry Steering Committee
….

“Due to the complexity of having five modules in one registry, we recognized potential data challenges for some sites. We collaborated with PatientIQ to help mitigate the burden and enhance data submission.Consequently, data within the registry has increased significantly and is helping fuel new momentum within the registry.”

Automating Registry Participation Within a Matter of Weeks
Utilizing FHIR-based APIs and other live integration functionality, PatientIQ can help extract and translate critical health information into registry-compliant specifications and submit it on behalf of participating orthopaedic surgeons. In doing so, the platform eases the administrative and technological burden associated with submitting procedural, post operative and patient-reported outcomes to the FTR.

Click here to watch a webinar discussing one customer’s journey with the FTR Powered by PatientIQ.

Hospital sites, ambulatory service centers or institutions where fracture and trauma-related incidents are treated are invited to participate in the FTR. Enrollment through PatientIQ is encouraged, but optional. To get involved with the FTR, email an AAOS Registry engagement associate at RegistryEngagement@aaos.org, call 847-292-0530, or click here. For more information about PatientIQ, visit www.patientiq.io.

SonoVascular Enters Into Strategic Collaboration with Lantheus Holdings | for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

"SonoVascular is honored to have the opportunity to partner with Lantheus, a leader in microbubble development," said Daniel Estay, Founder and Chief Executive Officer of SonoVascular. "Our SonoThrombectomy System, combined with Lantheus' microbubbles, is designed to provide a true, next-generation solution for the treatment of DVT and PE that overcomes the drawbacks associated with catheter-based thrombectomy and thrombolysis devices."

Anaut Announces Japanese Regulatory Approval of AI-Powered Surgical Visualization Tool, Eureka α

Eureka α utilizes state-of-the-art AI to analyze real-time video from laparoscopic and robotic surgery, enhancing surgeons' accuracy by highlighting the dissection planes characterized by connective tissue.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
SourceAAOS

By using this website you agree to accept Medical Device News Magazine Privacy Policy